Skip to content

20-321 - Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

Status: open

A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer

Patients with Pancreatic Cancer

Contact Us Or call (251) 445-9834

Description

This study will compare the usual treatment approach in treating pancreatic cancer (surgery followed by chemotherapy) to using chemotherapy before and after surgery. This study will help the study doctors find out if this different approach is better, the same, or worse than the usual approach. To decide if it is better, the study doctors will be looking to see if the study approach increases the life of patients compared to the usual approach.

Sponsors

This trial is sponsored by National Cancer Institute (NCI).

Providers Associated With This Trial

Sub Investigators

This link will open in a new tab or window.